Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy

Summary

The primary objective of this study is to demonstrate that SLIT administered pre-and co-seasonally is effective in reducing rhinoconjunctivitis symptoms during the entire short ragweed pollen season.

Timeline

Start

2011-04

Primary completion

2011-11

Completion

2012-04

Outcome

Met primary endpoint

registry Ragweed Allergenic Extract vs Placebo (Glycero-Cocas); p <0.05; Mean Difference (Net) -0.834 (95% CI -1.298 to -0.369); ANCOVA NCT01353079 ↗

Drugs

Indications